发明名称 |
Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2 |
摘要 |
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Uncoupling Protein 2 (UCP2), in particular, by targeting natural antisense polynucleotides of Uncoupling Protein 2 (UCP2). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of UCP2. |
申请公布号 |
US9068183(B2) |
申请公布日期 |
2015.06.30 |
申请号 |
US201013518226 |
申请日期 |
2010.12.23 |
申请人 |
CuRNA, Inc. |
发明人 |
Collard Joseph;Khorkova Sherman Olga |
分类号 |
C12N15/11;C12N5/00;C12N15/113;A61K31/7088 |
主分类号 |
C12N15/11 |
代理机构 |
CuRNA, Inc. |
代理人 |
CuRNA, Inc. ;Browder Monte R. |
主权项 |
1. A method of upregulating a function of and/or the expression of a Uncoupling Protein 2 (UCP2) polynucleotide in patient cells or tissues in vivo or in vitro, said patient having a UCP2 associated disease or disorder, comprising:
contacting said cells or tissues with at least one antisense oligonucleotide of 12-30 nucleotides in length that specifically targets and specifically hybridizes to a region of a natural antisense oligonucleotide of the Uncoupling Protein 2 (UCP2) polynucleotide selected from SEQ ID NOS: 2 or 3; thereby upregulating a function of and/or the expression of the Uncoupling Protein 2 (UCP2) polynucleotide in patient cells or tissues in vivo or in vitro. |
地址 |
Miami FL US |